Mode
Text Size
Log in / Sign up
Early Phase 1 Completed N=66 Randomized Single-blind Basic Science

Neural Mechanisms of Cannabinoid-impaired Decision-Making in Emerging Adults

Neurosciences · Substance-Related Disorders · Behavior Problem
Source: ClinicalTrials.gov NCT03944954 ↗
Enrolled (actual)
66
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Alpha Learning Rate — .62; .43; .55; .21 Alpha Coefficient

Summary

Emerging adults are a particularly vulnerable group for experiencing the immediate and potentially lifelong negative impacts of habitual cannabis use, and trends suggest that cannabis use disorder (CUD) will soon escalate in this population. The proposed research will combine clinical pharmacology, non-invasive brain stimulation, and neuroimaging techniques to establish the brain mechanisms of cannabinoid-impaired decision-making processes in emerging adults with CUD. Results from this project will inform CUD prevention/treatment efforts in this high-risk group and address a growing public health concern.

Outcome Measures

OutcomeResultp-value
PRIMARY
Alpha Learning Rate
.62; .43; .55; .21; .71; .53
PRIMARY
Self-Report Subjective "High"
2.9; 0; 13.8; 3.8; 24.6; 5
PRIMARY
Elasticity of Demand
.005; .004; .006; .007; .005; .003
PRIMARY
Working Memory Performance
98.0; 96.3; 93.0; 90; 90.1; 86.3

Eligibility Criteria

Inclusion Criteria

  • Habitual cannabis use problems
  • Body Mass Index ≤30

Exclusion Criteria

  • Past or current serious physical or mental health
  • Sesame seed oil allergy
  • Irregular health issues identified by the Study Physician
  • Standard magnetic resonance imaging and transcranial magnetic stimulation exclusion criteria (e.g., metal implants, history of epilepsy, etc.)
  • Lack of affective form of birth control (females)
  • Pregnancy (females)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03944954). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search